TerraLink to Distribute Regalia Maxx Biofungicide in Western Canada
DAVIS, Calif., April 16, 2019 (GLOBE NEWSWIRE) --
Marrone Bio Innovations
Inc. (MBII) (MBI), a leading developer
of biological crop protection and plant health solutions, today
announced that it has appointed TerraLink Horticulture, Inc.
(âTerraLinkâ) as a distributor of the Regalia® Maxx Biofungicide in
Western Canada.
TerraLink has been a leading supplier of crop input products to Western Canada since 1973. Based out of Abbotsford, BC, TerraLink primary focuses on providing farmers, production managers and professional growers with a comprehensive suite of fertilizers, seeds, growing media, hard goods and crop protection products.
âWe are pleased to announce our distribution partnership with TerraLink, which we expect to stimulate sales of our incredible Regalia Maxx Biofungicide throughout Western Canada,â said André Trépanier, director of marketing at Marrone Bio Innovations. âNow that we have received approval for our newly expanded label by the Canadian authorities, we are seeing a notable increase in grower inquiries due to its safety, crop quality and yield benefits as compared to existing chemical products. The expanded label also offers a unique value proposition to producers of medicinal plants in Canada, as it does not carry the same toxicity risk that traditional chemical pesticides do. We are looking forward to working with TerraLink to bring a new generation of sustainable farming practices to Western Canada,â concluded Trépanier.
About Regalia Maxx
Biofungicide
Regalia Maxx Biofungicide contains a plant extract made from the
giant knotweed (Reynoutria sachalinensis) plant. The
powerful biofungicide induces the plants' natural defense
mechanisms against tough fungal and bacterial diseases such as
powdery mildew and gray mold (Botrytis). Regalia Maxx
Biofungicide is registered on a wide range of crops including
greenhouse grown ornamentals, cucurbits, tomatoes, grapes, hops,
apples, trees fruits, blueberries and strawberries, turf and more.
Regalia Maxx Biofungicide is exempt from residue tolerances, and
OMRI listed, making it a good choice for organic and conventionally
grown crops. Regalia Maxx Biofungicide can be used in rotation
or as a tank mix partner with most commercially available
products.
About Marrone Bio
Innovations
Marrone Bio Innovations
Inc. (MBII) leads the movement to more
a sustainable world through the discovery, development and sale of
innovative biological products for crop protection, plant health
and waterway systems treatment that support a better tomorrow for
farmers, turf managers and consumers around the globe. MBI has
screened over 18,000 microorganisms and 350 plant extracts,
leveraging its in-depth knowledge of plant and soil microbiomes
enhanced by advanced molecular technologies to rapidly develop
seven effective and environmentally responsible pest
management active ingredients and nine commercial products to
help customers operate more sustainably while uniquely improving
plant health and increasing crop yields. Supported by a robust
portfolio of over 400 issued and pending patents around its
superior natural product chemistry, MBIâs currently available
commercial products, in addition to the Regalia® family, are
Stargus®, Grandevo®, Venerate®, Majestene®, Haven® and Amplitude®,
Zelto® and Zequanox®.
Learn more about Marrone Bio Innovations at www.marronebio.com. Follow us on social media: Twitter, LinkedIn and Instagram.
Marrone Bio Innovations Forward-Looking
Statements
This press release contains forward-looking statements that involve
substantial risks and uncertainties. All statements, other than
statements of historical facts, included in this press release
regarding strategy, future operations and plans, including
assumptions underlying such statements, are forward-looking
statements, including examples regarding the potential of and
market for MBIâs Regalia Maxx product and its use and value to
growers should not be relied upon as representing MBIâs views as of
any subsequent date. Examples of such statements include the
potential of the MBIâs products and market projections. Such
forward-looking statements are based on information available to
the Company as of the date of this release and involve a number of
risks and uncertainties, some beyond the Companyâs control, that
could cause actual results to differ materially from those
anticipated by these forward-looking statements, including weather,
regulatory and other factors affecting demand for the MBIâs
products, any difficulty in marketing MBIâs products in its target
markets, competition in the market for pest management products,
lack of understanding of bio-based pest management products by
customers and growers. Additional information that could lead to
material changes in MBIâs performance is contained in its filings
with the SEC. MBI is under no obligation to, and expressly
disclaims any responsibility to, update or alter forward-looking
statements contained in this release, whether as a result of
current information, future events or otherwise.
MBI Investor Relations:
Greg Falesnik, Managing Director
MZ Group â MZ North America
949-385-6449
[email protected]
www.mzgroup.us
MBI Trade Public
Relations:
Alicia Gillman, Marketing
Communications
480-889-4219
Email: [email protected]
Marrone Bio Innovations Product Development
Contact:
André Trépanier, Director of Marketing
Main: 530-750-2800
Email: [email protected]